Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
D1830
Boston, MA 02115Phone+1 617-632-6844Fax+1 617-632-4422
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995
- Duke University HospitalResidency, Internal Medicine, 1989 - 1992
- University of Massachusetts Medical SchoolClass of 1989
Certifications & Licensure
- MA State Medical License 1994 - 2026
- NH State Medical License 2009 - 2025
- NC State Medical License 1991 - 1998
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis
Blood Advances. 2025-02-11 - Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia.Christine E Ryan, Yue Ren, Svitlana Tyekucheva, Jon E Arnason, Adam M Boruchov
Hemasphere. 2025-01-01 - Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.Francine M Foss, Youn H Kim, H Miles Prince, Oleg E Akilov, Christiane Querfeld
Journal of Clinical Oncology. 2024-12-19
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: